dr. figlin discusses sequencing mtor inhibitors and tkis in rcc
Published 11 years ago • 262 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
0:59
dr. figlin discusses future of rcc treatment
-
1:54
dr. figlin on tki therapy options in renal cell carcinoma
-
1:18
dr. figlin on considerations for combining tkis and immunotherapy in rcc
-
1:18
dr. figlin on treatment strategies in advanced rcc
-
1:13
robert figlin, md, discusses sequencing when treating metastatic rcc patients
-
1:04
dr. figlin on intermediate prognosis patients with mrcc
-
6:40
perspectives on sequencing in metastatic renal cell carcinoma
-
1:24
dr. figlin on sunitinib for patients with rcc
-
0:53
dr. figlin on advances in immunotherapy for kidney cancer
-
1:15
dr. figlin on the plethora of novel agents in rcc
-
1:57
dr. robert figlin on the increasingly complicated treatment paradigm for renal cell carcinoma
-
1:02
dr. figlin on advice for oncologists treating rcc
-
1:12
dr. figlin describes the efficacy of ags-003 in mrcc
-
0:54
dr. lee on sequencing therapies for patients with rcc
-
7:24
second-line treatments in rcc
-
1:03
dr. robert figlin describes the efficacy of ags-003 in mrcc
-
8:10
choosing among tkis in advanced rcc
-
0:54
dr. rini on sequencing of immunotherapy combinations in rcc
-
1:17
dr. figlin on the evolving treatment landscape of renal cell carcinoma